WallStreetZenWallStreetZen

NASDAQ: INMB
Inmune Bio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for INMB

Based on 2 analysts offering 12 month price targets for Inmune Bio Inc

Min Forecast
$0.60-68.09%
Avg Forecast
$4.30+128.72%
Max Forecast
$8.00+325.53%

Should I buy or sell INMB stock?

Based on 2 analysts offering ratings for Inmune Bio Inc.

Buy
Strong Buy
1 analysts 50%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
1 analysts 50%
Strong Sell
0 analysts 0%
Although INMB's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates INMB as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their INMB stock forecasts and price targets.

INMB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-07-02
lockedlocked$00.00+00.00%2025-07-01

1 of 1

Forecast return on equity

Is INMB forecast to generate an efficient return?

Company
-83.34%
Industry
261.51%
Market
228.88%
INMB's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is INMB forecast to generate an efficient return on assets?

Company
-63.41%
Industry
91.4%
INMB is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

INMB earnings per share forecast

What is INMB's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
-$1.77
Avg 2 year Forecast
-$1.30
Avg 3 year Forecast
-$1.10

INMB revenue forecast

What is INMB's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$38.3k-23.5%
Avg 2 year Forecast
$4.9M+9,718%
Avg 3 year Forecast
$7.7M+15,230%
INMB's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

INMB revenue growth forecast

How is INMB forecast to perform vs Biotechnology companies and vs the US market?

Company
445.37%
Industry
102.76%
Market
25.69%
INMB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
INMB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

INMB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
INMB$1.88$4.30+128.72%Buy
BCAB$0.85N/AN/A
IBO$0.47N/AN/A
IOBT$0.68$3.50+416.22%Strong Buy
HOWL$1.00$5.00+402.01%Strong Buy
View Top Biotech Stocks

Inmune Bio Stock Forecast FAQ

Is Inmune Bio Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: INMB) stock is to Buy INMB stock.

Out of 2 analysts, 1 (50%) are recommending INMB as a Strong Buy, 0 (0%) are recommending INMB as a Buy, 0 (0%) are recommending INMB as a Hold, 1 (50%) are recommending INMB as a Sell, and 0 (0%) are recommending INMB as a Strong Sell.

If you're new to stock investing, here's how to buy Inmune Bio stock.

What is INMB's earnings growth forecast for 2025-2027?

(NASDAQ: INMB) Inmune Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 45.14%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.81%.

Inmune Bio's earnings in 2025 is -$49,887,000.On average, 8 Wall Street analysts forecast INMB's earnings for 2025 to be -$47,093,126, with the lowest INMB earnings forecast at -$50,543,893, and the highest INMB earnings forecast at -$37,684,603. On average, 8 Wall Street analysts forecast INMB's earnings for 2026 to be -$34,656,542, with the lowest INMB earnings forecast at -$60,444,243, and the highest INMB earnings forecast at -$20,098,455.

In 2027, INMB is forecast to generate -$29,286,320 in earnings, with the lowest earnings forecast at -$36,474,974 and the highest earnings forecast at -$14,236,406.

What is INMB's revenue growth forecast for 2025-2027?

(NASDAQ: INMB) Inmune Bio's forecast annual revenue growth rate of 445.37% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 102.76%, and it is also forecast to beat the US market's average forecast revenue growth rate of 25.69%.

Inmune Bio's revenue in 2025 is $50,000.On average, 8 Wall Street analysts forecast INMB's revenue for 2025 to be $1,016,886, with the lowest INMB revenue forecast at $0, and the highest INMB revenue forecast at $1,395,726. On average, 8 Wall Street analysts forecast INMB's revenue for 2026 to be $130,507,032, with the lowest INMB revenue forecast at $0, and the highest INMB revenue forecast at $403,032,511.

In 2027, INMB is forecast to generate $203,776,003 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $423,742,427.

What is INMB's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: INMB) forecast ROA is -63.41%, which is lower than the forecast US Biotechnology industry average of 91.4%.

What is INMB's Price Target?

According to 2 Wall Street analysts that have issued a 1 year INMB price target, the average INMB price target is $4.30, with the highest INMB stock price forecast at $8.00 and the lowest INMB stock price forecast at $0.60.

On average, Wall Street analysts predict that Inmune Bio's share price could reach $4.30 by Jul 2, 2026. The average Inmune Bio stock price prediction forecasts a potential upside of 128.72% from the current INMB share price of $1.88.

What is INMB's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: INMB) Inmune Bio's current Earnings Per Share (EPS) is -$2.12. On average, analysts forecast that INMB's EPS will be -$1.77 for 2025, with the lowest EPS forecast at -$1.90, and the highest EPS forecast at -$1.42. On average, analysts forecast that INMB's EPS will be -$1.30 for 2026, with the lowest EPS forecast at -$2.27, and the highest EPS forecast at -$0.76. In 2027, INMB's EPS is forecast to hit -$1.10 (min: -$1.37, max: -$0.54).

What is INMB's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: INMB) forecast ROE is -83.34%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.